Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Myelodysplastic Syndromes 1Leukemia, Myeloid, Acute 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Graft vs Host Disease 1

Interventions

Cyclophosphamide 38Tacrolimus 35Methotrexate 29fludarabine phosphate 24Busulfan 24Cyclosporine 23Antilymphocyte Serum 23Mycophenolic Acid 20fludarabine 18Peripheral Blood Stem Cell Transplantation 18Melphalan 18Methylprednisolone 16Filgrastim 16Radiotherapy 15Sirolimus 14Whole-Body Irradiation 13thymoglobulin 8Stem Cell Transplantation 8Thiotepa 7Cord Blood Stem Cell Transplantation 7Granulocyte Colony-Stimulating Factor 6Transplantation 5Hematopoietic Stem Cell Transplantation 5Flow Cytometry 5Etoposide 5Alemtuzumab 5Cyclosporins 4Bone Marrow Transplantation 4Therapeutics 3Prednisone 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Graft vs Host Disease × Clinical Trials, Phase I as Topic × Myeloid × Clear all
NCT03533816 2026-03-25

Expanded/Activated Gamma Delta T-cell Infusion Following Hematopoietic Stem Cell Transplantation and Post-transplant Cyclophosphamide

University of Kansas Medical Center

Phase 1 Recruiting
38 enrolled
LymphoidMyeloidOther hematologic neoplasm

Graft vs Host Disease, Myelodysplastic Syndromes, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡